Equity · Healthcare
OGN
NYSEOrganon & Co. (OGN)
The line runs 13.66 USD on 11 August through 13.85 USD on 6 November, on a scale from 13.6 to 13.9. Days the market did not trade hold the previous close, flat.
- Market cap
- 3.6B USD
- P/E (TTM)
- 18.0
- Revenue, year to Dec 2025
- 6.2B USD
- EPS, diluted, year to Dec 2025
- 0.72 USD
- 52-week range
- 5.70 USD – 13.85 USD
- Avg volume
- 162.8K
- Mentions, 30 days
- 1
as of Nov 6, 2026
Have Organon & Co. (OGN) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, no Organon & Co. insider bought or sold shares on the open market; all 2 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 10 Nov 2026, newest Form 4 filing 11 Aug 2026
Buys 0Sells 0Other filings 2
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 11 Aug 2026 | Arjona Ferreira Juan CamiloHead of R&D & CMO | Option exercise | 11,519 | |
| 11 Aug 2026 | Arjona Ferreira Juan CamiloHead of R&D & CMO | Tax withheld | 4,134 | 56K USD |
Which funds hold Organon & Co. (OGN)?
10 of the 45 institutional funds we track reported a Organon & Co. position for the quarter ended 30 Jun 2026 — a combined 180.0M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Man Group | New position | 4,180,500 | 56.6M USD | |
| Millennium Management | Trimmed | 3,442,430 | 46.6M USD | −49.2% |
| Balyasny Asset Management | Added | 2,196,642 | 29.7M USD | +908.1% |
| AQR Capital Management | Trimmed | 1,245,588 | 16.8M USD | −63.9% |
| Marshall Wace | Held (±25%) | 828,133 | 11.2M USD | −11.3% |
| D. E. Shaw & Co. | Trimmed | 718,753 | 9.7M USD | −72.8% |
| Citadel Advisors | Trimmed | 344,359 | 4.7M USD | −82.8% |
| Two Sigma Investments | Trimmed | 241,392 | 3.3M USD | −92.3% |
| GAMCO Investors | New position | 86,872 | 1.2M USD | |
| Tudor Investment Corp | Trimmed | 11,180 | 151K USD | −70.2% |
Have members of Congress traded Organon & Co. (OGN)?
The most recent congressional trade disclosed in Organon & Co. is a sale by Kevin Hern (house, OK), dated 05 Aug 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 05 Aug 2026 | Kevin Hernhouse · Republican–OK | Sale | 1K USD–15K USD | 5 days |
What has been filed or recorded for Organon & Co. (OGN)?
The filings we hold for Organon & Co., newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 07 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 475 shares | 7K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 5 shares | 69 USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.60 USD | Revenue $1.57B |
| 30 Sep 2026 | Financials | Total assets | 13.4B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 1.2B USD | at period end |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 474 shares | 7K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 0.40 USD | Revenue $1.56B |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.55 USD | Revenue $1.46B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 0.72 USD | Revenue $6.22B |
| 31 Dec 2025 | Financials | Revenue | 6.2B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 187.0M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 0.72 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.61 USD | Revenue $1.60B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.56 USD | Revenue $1.59B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.33 USD | Revenue $1.51B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 3.33 USD | Revenue $6.40B |
What is Reddit saying about Organon & Co. (OGN)?
Reddit mentioned OGN 1 times in the 30 days to 9 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 0% read bullish, 0% bearish and 100% neither. Reddit data updated 9 November 2026.
30-day window, Method
Mentions, 30 days 1Communities 1
How do Reddit mentions of Organon & Co. (OGN) compare with its price?
Share ↗
Where Organon & Co. (OGN) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 1 | +0.01 |
Organon & Co. (OGN): frequently asked questions
What did Organon & Co. shares close at?
Organon & Co. closed at 13.85 USD on 6 Nov 2026, up 0.44% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Organon & Co.’s market cap?
Organon & Co. is worth 3.6B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Organon & Co.’s P/E ratio?
Organon & Co. has a price-to-earnings ratio of 18.0, as of 6 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Organon & Co.’s revenue?
Organon & Co. reported revenue of 6.2B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Organon & Co. insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, no Organon & Co. insider bought or sold shares on the open market; all 2 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Organon & Co.?
10 of the 45 funds we track reported a Organon & Co. position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Man Group, Millennium Management and Balyasny Asset Management. See Funds
Have members of Congress traded Organon & Co.?
Yes. 1 trade in Organon & Co. appears in the congressional disclosures we hold: a sale by Kevin Hern (House, OK) dated 5 Aug 2026, filed 10 Aug 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Organon & Co. last report earnings?
Organon & Co. last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.60 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Organon & Co.?
Organon & Co. was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 0% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings